|
Sight Sciences, Inc. (SGHT) DCF -Bewertung
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Sight Sciences, Inc. (SGHT) Bundle
Möchten Sie den inneren Wert von Sight Sciences, Inc. bewerten? Unser SGHT DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsoptionen, sodass Sie Ihre Prognosen verfeinern und Ihre Anlagestrategien verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.3 | 27.6 | 49.0 | 71.3 | 81.1 | 112.4 | 156.0 | 216.3 | 300.1 | 416.2 |
| Revenue Growth, % | 0 | 18.38 | 77.12 | 45.7 | 13.63 | 38.71 | 38.71 | 38.71 | 38.71 | 38.71 |
| EBITDA | -23.5 | -31.7 | -57.2 | -80.5 | -49.4 | -103.7 | -143.8 | -199.4 | -276.6 | -383.7 |
| EBITDA, % | -100.51 | -114.6 | -116.85 | -112.82 | -60.96 | -92.19 | -92.19 | -92.19 | -92.19 | -92.19 |
| Depreciation | .4 | 1.1 | 1.2 | 1.3 | .6 | 2.4 | 3.4 | 4.7 | 6.5 | 9.0 |
| Depreciation, % | 1.85 | 4.04 | 2.45 | 1.76 | 0.7575 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 |
| EBIT | -23.9 | -32.8 | -58.4 | -81.7 | -50.0 | -103.8 | -144.0 | -199.8 | -277.1 | -384.4 |
| EBIT, % | -102.36 | -118.64 | -119.3 | -114.58 | -61.72 | -92.34 | -92.34 | -92.34 | -92.34 | -92.34 |
| Total Cash | 21.2 | 61.5 | 260.7 | 185.0 | 138.1 | 110.4 | 153.1 | 212.4 | 294.6 | 408.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4.1 | 5.4 | 8.7 | 15.1 | 14.3 | 21.0 | 29.2 | 40.5 | 56.2 | 77.9 |
| Account Receivables, % | 17.53 | 19.4 | 17.79 | 21.24 | 17.63 | 18.72 | 18.72 | 18.72 | 18.72 | 18.72 |
| Inventories | 2.2 | 2.6 | 3.5 | 6.1 | 7.8 | 10.0 | 13.8 | 19.2 | 26.6 | 36.9 |
| Inventories, % | 9.61 | 9.4 | 7.1 | 8.57 | 9.68 | 8.87 | 8.87 | 8.87 | 8.87 | 8.87 |
| Accounts Payable | 2.3 | 2.2 | 3.4 | 2.7 | 1.7 | 6.9 | 9.5 | 13.2 | 18.3 | 25.4 |
| Accounts Payable, % | 9.92 | 7.81 | 6.84 | 3.77 | 2.14 | 6.09 | 6.09 | 6.09 | 6.09 | 6.09 |
| Capital Expenditure | -.7 | -1.0 | -.8 | -1.0 | -.8 | -2.3 | -3.2 | -4.5 | -6.2 | -8.6 |
| Capital Expenditure, % | -2.88 | -3.45 | -1.66 | -1.36 | -0.97587 | -2.06 | -2.06 | -2.06 | -2.06 | -2.06 |
| Tax Rate, % | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 | -0.19842 |
| EBITAT | -23.9 | -32.8 | -58.6 | -81.8 | -50.1 | -103.8 | -144.0 | -199.8 | -277.1 | -384.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -28.2 | -34.5 | -61.2 | -91.2 | -52.1 | -107.5 | -153.2 | -212.5 | -294.8 | -408.9 |
| WACC, % | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 | 15.76 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -705.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -417 | |||||||||
| Terminal Value | -3,031 | |||||||||
| Present Terminal Value | -1,458 | |||||||||
| Enterprise Value | -2,163 | |||||||||
| Net Debt | -103 | |||||||||
| Equity Value | -2,060 | |||||||||
| Diluted Shares Outstanding, MM | 49 | |||||||||
| Equity Value Per Share | -42.37 |
What You Will Get
- Real SGHT Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Sight Sciences' future performance.
- User-Friendly Design: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data: Sight Sciences’ historical financial statements and detailed forecasts.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins.
- Real-Time Insights: View Sight Sciences’ intrinsic value updates instantly.
- Intuitive Visualizations: Dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A robust tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file for Sight Sciences, Inc. (SGHT).
- Step 2: Review the pre-filled financial data and forecasts for Sight Sciences.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose This Calculator for Sight Sciences, Inc. (SGHT)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your financial analysis.
- Real-Time Valuation: Observe immediate updates to Sight Sciences’ valuation with every input change.
- Preloaded Data: Comes equipped with Sight Sciences’ actual financial metrics for swift evaluations.
- Relied Upon by Experts: Trusted by investors and analysts for making strategic decisions.
Who Should Use This Product?
- Healthcare Professionals: Understand the latest advancements in ophthalmic technologies and their applications.
- Researchers: Utilize innovative models to enhance studies related to eye care and surgery.
- Investors: Evaluate your investment strategies by analyzing the performance metrics of Sight Sciences, Inc. (SGHT).
- Medical Analysts: Optimize your analysis with a tailored financial model specific to the healthcare sector.
- Entrepreneurs: Discover how established companies like Sight Sciences, Inc. (SGHT) approach market challenges and opportunities.
What the Template Contains
- Pre-Filled DCF Model: Sight Sciences, Inc.'s (SGHT) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to Sight Sciences, Inc. (SGHT).
- Financial Ratios: Evaluate Sight Sciences, Inc.'s (SGHT) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios for Sight Sciences, Inc. (SGHT).
- Financial Statements: Annual and quarterly reports to support detailed analysis of Sight Sciences, Inc. (SGHT).
- Interactive Dashboard: Easily visualize key valuation metrics and results for Sight Sciences, Inc. (SGHT).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.